Manufacturers Life Insurance Company, The Day One Biopharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 50,368 shares of DAWN stock, worth $690,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,368
Previous 40,878
23.22%
Holding current value
$690,545
Previous $596,000
39.6%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$88.2 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$65.5 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$52.2 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$39.7 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.01B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...